{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/childhood-cancers-recognition-referral/management/referral-for-childhood-cancer/","result":{"pageContext":{"chapter":{"id":"9b20132e-fc62-5498-bc5b-bd6c252ddaba","slug":"referral-for-childhood-cancer","fullItemName":"Scenario: Referral for childhood cancer","depth":2,"htmlHeader":"<!-- begin field fffeaf38-509e-489f-946d-53edc683b19a --><h2>Scenario: Referral for childhood cancer</h2><!-- end field fffeaf38-509e-489f-946d-53edc683b19a -->","summary":"Covers the referral of children with suspected neuroblastoma, retinoblastoma, and Wilms' tumour.","htmlStringContent":"<!-- begin item 3ead2485-4e6d-4875-bb22-8c0b1eeede4b --><!-- begin field 8e8c7d4d-f1b7-4af7-95a1-acd900abf355 --><p>From birth to 15 years.</p><!-- end field 8e8c7d4d-f1b7-4af7-95a1-acd900abf355 --><!-- end item 3ead2485-4e6d-4875-bb22-8c0b1eeede4b -->","topic":{"id":"7ea64737-af89-5cad-8f33-2466d98eab3a","topicId":"360677c6-0adf-45e4-87f1-98b0ab02c557","topicName":"Childhood cancers - recognition and referral","slug":"childhood-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"3a84248b-68fe-535d-a2c8-570960c744af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6172d98b-b3d3-59d4-bfcb-f0d787673884","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"82d59d36-e24e-5089-8870-952cec58c93b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"951de1cf-297e-5e28-90f7-2b482a3f73d4","slug":"changes","fullItemName":"Changes"},{"id":"93b60b97-3e26-5b64-a493-791a75266270","slug":"update","fullItemName":"Update"}]},{"id":"43a3c8ca-4187-59d9-b1af-842bda4159f8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"311645ef-ef46-5c04-a220-135331185f90","slug":"goals","fullItemName":"Goals"},{"id":"25f3b274-a4d7-5071-9854-87246c3a13d6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d04c3c26-8145-5dd2-9e26-642ebe9403d7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"2ae9f6b6-9722-5f17-b601-6f5ca8bbc2eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6ea5d6b9-bf9c-5af9-a190-d7e85fff8f9e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c18ccf4b-f36f-5964-9349-a4df758477cf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"72c67f25-10a7-5403-9703-3d9ad04a8380","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"01e81a55-6bee-51de-aedd-b3ea05d76543","slug":"presentation","fullItemName":"Presentation"},{"id":"2215b91a-bd85-5aed-90b6-b60a0f60d97a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c0f388f6-353d-5487-a0f8-56810c177100","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"0d6dd33b-1d1d-5771-8320-f4e841ce74fa","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"2e4faf68-8401-5c16-9d89-770cc18882a3","slug":"symptoms-suggestive-of-childhood-cancers","fullItemName":"Symptoms suggestive of childhood cancers"}]},{"id":"19af95ab-b078-594b-932d-3074d78cb9b9","fullItemName":"Management","slug":"management","subChapters":[{"id":"9b20132e-fc62-5498-bc5b-bd6c252ddaba","slug":"referral-for-childhood-cancer","fullItemName":"Scenario: Referral for childhood cancer"}]},{"id":"de444d47-41bb-5be6-b33b-fc41c6e13a49","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5dfa2066-b9e3-5a5c-be41-3da82cb05300","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9cfbb0ba-ff92-51ce-a490-6ace179004d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3f8a16c9-f714-5289-8a66-8d861806d96b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c9760bd6-f6e4-5c9f-b95f-5752eacf9a60","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a2bdc201-80f4-59a0-8b55-6bddee928f07","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b3bd003f-40eb-5d7a-8811-26a73328252e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4c1d9926-b6f9-568c-9a48-3017aeed0ee8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"19af95ab-b078-594b-932d-3074d78cb9b9","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"2026f42d-3168-5d45-a2a9-0d51a02597bc","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field d8fc1b69-92d7-4ce6-ad62-8979907e4d58 --><h3>Referral timelines</h3><!-- end field d8fc1b69-92d7-4ce6-ad62-8979907e4d58 -->","summary":null,"htmlStringContent":"<!-- begin item 43ab5c9a-bf1f-4c0b-a6c9-9b00f854f33e --><!-- begin field b8192291-84ee-492b-92ba-d6e4595cf4a6 --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<br><ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals.</li></ul></li></ul><!-- end field b8192291-84ee-492b-92ba-d6e4595cf4a6 --><!-- end item 43ab5c9a-bf1f-4c0b-a6c9-9b00f854f33e -->","subChapters":[{"id":"f448a676-80ed-5b37-909a-9b3855e1cea0","slug":"basis-for-recommendation-457","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9ac5ac56-9d2c-410b-b448-8fba5ab13349 --><h4>Basis for recommendation</h4><!-- end field 9ac5ac56-9d2c-410b-b448-8fba5ab13349 -->","summary":null,"htmlStringContent":"<!-- begin item 4575e24d-6f59-47cc-a178-96542f1c6ac7 --><!-- begin field 8fd26519-d410-469a-82c3-1ba4d9171d57 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 8fd26519-d410-469a-82c3-1ba4d9171d57 --><!-- end item 4575e24d-6f59-47cc-a178-96542f1c6ac7 -->","subChapters":[]}]},{"id":"4a7d8310-b174-56ca-9e4a-fde818a2c1be","slug":"referral-for-suspected-neuroblastoma","fullItemName":"Referral for suspected neuroblastoma","depth":3,"htmlHeader":"<!-- begin field 79080faf-ae73-4cfe-ade3-8588f872395c --><h3>When should I refer a child with suspected neuroblastoma?</h3><!-- end field 79080faf-ae73-4cfe-ade3-8588f872395c -->","summary":null,"htmlStringContent":"<!-- begin item 3b7bff02-6e31-4074-9fd4-d10e2327aea7 --><!-- begin field ddd11cf4-f59a-4eab-9ab3-a52aa3fcd370 --><ul><li><strong>Consider very urgent referral </strong>(for an appointment within 48 hours) for specialist assessment for neuroblastoma in children with a palpable abdominal mass or unexplained enlarged abdominal organ (new NICE recommendation for 2015).</li></ul><!-- end field ddd11cf4-f59a-4eab-9ab3-a52aa3fcd370 --><!-- end item 3b7bff02-6e31-4074-9fd4-d10e2327aea7 -->","subChapters":[{"id":"da9d1d06-3fb9-5117-95da-6c4a0562dc58","slug":"basis-for-recommendation-0c2","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 721c0b25-e2ff-42d9-897b-d0cec44e1f6a --><h4>Basis for recommendation</h4><!-- end field 721c0b25-e2ff-42d9-897b-d0cec44e1f6a -->","summary":null,"htmlStringContent":"<!-- begin item 0c2c70d1-3ceb-4daf-b722-a327fda5df0c --><!-- begin field a56729d1-aedf-4c18-91a7-a1ed11f240e5 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field a56729d1-aedf-4c18-91a7-a1ed11f240e5 --><!-- end item 0c2c70d1-3ceb-4daf-b722-a327fda5df0c -->","subChapters":[]}]},{"id":"9b2d9153-f581-5193-a8d6-555bb854d4eb","slug":"referral-for-suspected-retinoblastoma","fullItemName":"Referral for suspected retinoblastoma","depth":3,"htmlHeader":"<!-- begin field e4a4d23a-b5d5-4a01-bacd-99499fff9479 --><h3>When should I refer a child with suspected retinoblastoma?</h3><!-- end field e4a4d23a-b5d5-4a01-bacd-99499fff9479 -->","summary":null,"htmlStringContent":"<!-- begin item 5af5e0c8-3096-4f6d-9a54-b44f30499690 --><!-- begin field 55b9b039-e75c-4ca3-bf7a-2a99cc903bcd --><ul><li><strong>Consider urgent referral </strong>(for an appointment within 2 weeks) for ophthalmological assessment for retinoblastoma in children with an absent red reflex (new NICE recommendation for 2015).</li></ul><!-- end field 55b9b039-e75c-4ca3-bf7a-2a99cc903bcd --><!-- end item 5af5e0c8-3096-4f6d-9a54-b44f30499690 -->","subChapters":[{"id":"e1e8a4e5-da80-53b9-a22d-aff754da5811","slug":"basis-for-recommendation-74c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7b0a8688-6750-4738-b95b-1ffa9bba8b7e --><h4>Basis for recommendation</h4><!-- end field 7b0a8688-6750-4738-b95b-1ffa9bba8b7e -->","summary":null,"htmlStringContent":"<!-- begin item 74c2a5cf-e079-4890-91df-5439c7b651a9 --><!-- begin field 8c96d898-e08f-4652-8e33-79d7683779ea --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 8c96d898-e08f-4652-8e33-79d7683779ea --><!-- end item 74c2a5cf-e079-4890-91df-5439c7b651a9 -->","subChapters":[]}]},{"id":"7eee751e-a2e4-5bf7-9336-a64d129bfc17","slug":"referral-for-suspected-wilms-tumour","fullItemName":"Referral for suspected Wilms tumour","depth":3,"htmlHeader":"<!-- begin field 18df2afa-38d0-44bd-abf5-d2138199001f --><h3>When should I refer a child with suspected Wilms’ tumour?</h3><!-- end field 18df2afa-38d0-44bd-abf5-d2138199001f -->","summary":null,"htmlStringContent":"<!-- begin item 025af8be-5fb7-41bc-a902-2be5cf3caab9 --><!-- begin field 223f18d5-f4a2-4406-ba0d-560a88591ee2 --><ul><li><strong>Consider very urgent referral </strong>(for an appointment within 48 hours) for specialist assessment for Wilms' tumour in children with any of the following:<ul><li>A palpable abdominal mass.</li><li>An unexplained enlarged abdominal organ.</li><li>Unexplained visible haematuria (new NICE recommendation for 2015).</li></ul></li></ul><!-- end field 223f18d5-f4a2-4406-ba0d-560a88591ee2 --><!-- end item 025af8be-5fb7-41bc-a902-2be5cf3caab9 -->","subChapters":[{"id":"087ecaf9-cf01-590d-a8f5-72cca716f69c","slug":"basis-for-recommendation-ccd","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f020e539-f35a-43de-9420-f84ab9a2c8b0 --><h4>Basis for recommendation</h4><!-- end field f020e539-f35a-43de-9420-f84ab9a2c8b0 -->","summary":null,"htmlStringContent":"<!-- begin item ccd89589-de95-4ea1-ab56-70f81c2dd88f --><!-- begin field dafe47da-cb31-48dc-b61c-c267ea28d0ba --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field dafe47da-cb31-48dc-b61c-c267ea28d0ba --><!-- end item ccd89589-de95-4ea1-ab56-70f81c2dd88f -->","subChapters":[]}]},{"id":"d2a9572c-fd7b-5005-9136-9a6b73fc4073","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 9d5ccee5-0b75-4cca-acc9-88db7f8d9269 --><h3>Diagnostic and referral process</h3><!-- end field 9d5ccee5-0b75-4cca-acc9-88db7f8d9269 -->","summary":null,"htmlStringContent":"<!-- begin item 19fc7c23-ecab-4bc9-a5de-08d1d6109371 --><!-- begin field 4f52cacd-1cbb-43ef-bebd-36b4e71fbb25 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field 4f52cacd-1cbb-43ef-bebd-36b4e71fbb25 --><!-- end item 19fc7c23-ecab-4bc9-a5de-08d1d6109371 -->","subChapters":[{"id":"580cc715-e01d-5e55-88b4-ce2f2398060e","slug":"basis-for-recommendation-d78","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ab4885c2-90a9-4ae7-b186-757f7ec55307 --><h4>Basis for recommendation</h4><!-- end field ab4885c2-90a9-4ae7-b186-757f7ec55307 -->","summary":null,"htmlStringContent":"<!-- begin item d78437ab-30aa-4fc7-aa6a-860714243a39 --><!-- begin field 395f5fc8-2998-42ce-8e5b-3e20780e9e15 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 395f5fc8-2998-42ce-8e5b-3e20780e9e15 --><!-- end item d78437ab-30aa-4fc7-aa6a-860714243a39 -->","subChapters":[]}]},{"id":"2d12fe12-b271-51f6-82b2-a1007c8171df","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field 6bbca389-f98e-4089-a9f6-ddd9d6ef28f5 --><h3>What patient information and support should I offer?</h3><!-- end field 6bbca389-f98e-4089-a9f6-ddd9d6ef28f5 -->","summary":null,"htmlStringContent":"<!-- begin item 58ee333c-8197-4de2-92bd-8647fccc0cc4 --><!-- begin field ccfd5c49-260c-4694-b6ea-0ab7ac770069 --><ul><li>Discuss with people with suspected cancer (and their parents and/or carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field ccfd5c49-260c-4694-b6ea-0ab7ac770069 --><!-- end item 58ee333c-8197-4de2-92bd-8647fccc0cc4 -->","subChapters":[{"id":"d5b8fb48-9177-5aba-8a7b-86280a914046","slug":"basis-for-recommendation-3f6","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c62f50b9-cb59-442d-a71c-b8dce6fbdcad --><h4>Basis for recommendation</h4><!-- end field c62f50b9-cb59-442d-a71c-b8dce6fbdcad -->","summary":null,"htmlStringContent":"<!-- begin item 3f6b01bf-a5ce-41cc-9451-bee19d9c5bfd --><!-- begin field edf4112d-b670-4b38-b4a9-ef815f2b970f --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field edf4112d-b670-4b38-b4a9-ef815f2b970f --><!-- end item 3f6b01bf-a5ce-41cc-9451-bee19d9c5bfd -->","subChapters":[]}]},{"id":"7f124ac3-54de-5f52-bd5a-ecbb9a73e164","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field 46e327ad-3e1c-46a4-8f22-15f078aab2bd --><h3>Safety netting</h3><!-- end field 46e327ad-3e1c-46a4-8f22-15f078aab2bd -->","summary":null,"htmlStringContent":"<!-- begin item 491133b5-e876-471f-a611-bd99371c006c --><!-- begin field c673ed05-c376-4267-b441-e10fddba8661 --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field c673ed05-c376-4267-b441-e10fddba8661 --><!-- end item 491133b5-e876-471f-a611-bd99371c006c -->","subChapters":[{"id":"23a5e6bd-c2f4-54f5-a0fe-7de68e9fc6cb","slug":"basis-for-recommendation-229","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7d8e7d02-a3af-4a6e-bdfe-0dcf71eeb368 --><h4>Basis for recommendation</h4><!-- end field 7d8e7d02-a3af-4a6e-bdfe-0dcf71eeb368 -->","summary":null,"htmlStringContent":"<!-- begin item 22974b72-d56b-46d1-9e30-99da7e0dae27 --><!-- begin field 89cf9d44-8070-4643-bdc7-4ea080651587 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/childhood-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 89cf9d44-8070-4643-bdc7-4ea080651587 --><!-- end item 22974b72-d56b-46d1-9e30-99da7e0dae27 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}